tamsulosin hydrochloride NDC 72865-350

NDC codes

FDA NDC Directory

Product NDC (as listed)72865-350Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72865-0350Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72865-350-05	72865035005	500 CAPSULE in 1 BOTTLE (72865-350-05)Marketed from Jan 1, 2026
72865-350-90	72865035090	90 CAPSULE in 1 BOTTLE (72865-350-90)Marketed from Jan 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): tamsulosin hydrochloride
Generic name (nonproprietary): tamsulosin hydrochloride
Active ingredients: Tamsulosin hydrochloride — .4 mg/1
Dosage form: Capsule
Route: Oral
Labeler: XLCare Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214730
Marketing start: Jan 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 72865-350_9f4e621f-46a0-4d70-81cf-b6eb560383caSPL ID 9f4e621f-46a0-4d70-81cf-b6eb560383caSPL set ID 00097e78-9c04-4e62-8260-ddb50e9a6a93RxCUI 863669UNII 11SV1951MRUPC 0372865350058, 0372865350904
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472865035005 followed by a unit qualifier and the quantity

Package 72865-0350-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2026.

Indications (excerpt from the label)

Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies (14)]. Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension. Tamsulosin hydrochloride capsules are an alpha 1 adrenoceptor antagonist indicated for treatment of the signs and symptoms of benign prostatic hyperplasia (1) Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214730

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214730
Product	Strength	Form · route	Labeler	Product NDC
Tamsulosin Hydrochloride	Tamsulosin hydrochloride .4 mg/1	CapsuleOral	XLCare Pharmaceuticals, Inc	72865-282